Microbot Medical Inc. (MBOT) P/E Ratio History
Historical price-to-earnings valuation from 2017 to 2017
Loading P/E history...
MBOT Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Microbot Medical Inc. (MBOT) trades at a price-to-earnings ratio of -2.9x, with a stock price of $2.13 and trailing twelve-month earnings per share of $-0.27.
The current P/E is 135% below its 5-year average of 8.4x. Over the past five years, MBOT's P/E has ranged from a low of 8.4x to a high of 8.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, MBOT trades at a 113% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, MBOT trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MBOT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MBOT P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $161B | 57.6 | 2.65 | +23% | |
| $100B | 21.6 | - | +31% | |
| $113B | 35.0 | 2.36 | +8% | |
| $84B | 29.2 | - | +55% | |
| $151B | 11.4Lowest | 0.38Best | +134%Best | |
| $16B | 23.5 | - | -20% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
MBOT Historical P/E Data (2017–2017)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2017 Q3 | Sat Sep 30 2017 00:00:00 GM | $17.55 | $2.09 | 8.4x | +0% |
Average P/E for displayed period: 8.4x
See MBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MBOT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MBOT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMBOT — Frequently Asked Questions
Quick answers to the most common questions about buying MBOT stock.
Is MBOT stock overvalued or undervalued?
MBOT trades at -2.9x P/E, below its 5-year average of 8.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does MBOT's valuation compare to peers?
Microbot Medical Inc. P/E of -2.9x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is MBOT's PEG ratio?
MBOT PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2017-2017.